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A. Rumball-Smith, I.A. Wright and T.M. Buckenham*Radiology Department, Christchurch Hospital, Riccarton Avenue, Private Bag 4710,
Christchurch, New ZealandObjectives. Endovascular repair of abdominal aortic aneurysm is a technology that has undergone rapid technological
evolution with a number of different types of grafts developed and concern has been the structural integrity of the metallic
endoskeleton. We describe our experiences of strut failure in the Zenith abdominal aneurysm endograft device.
Design/materials/methods. Eighty-four patients have undergone endovascular repair of their abdominal aortic aneurysm
at Christchurch Hospital from 1996 to 2005, all with the Zenith endoprosthesis. All available plain radiographs of the
endoprosthesis (AP and lateral planes) were reviewed retrospectively, by a single experience observer, to assess strut failure.
Results. Three cases of strut failure in second-generation grafts were identified, each in the inferior body of the graft above
the iliac bifurcation. There was no clear evidence that these strut failures were associated with clinical complications.
Conclusion. This is the first time that strut failure in the Zenith abdominal endoprosthesis has been reported. Whilst in each
of our three cases this does not appear to have been of clinical significance, these findings re-iterate the necessity of life-long
surveillance of this technology.Keywords: Aortic aneurysm; Zenith; Stent-graft; Strut failure; Follow-up; Endovascular.Introduction
Endovascular repair of abdominal aortic aneurysms
was first described in 1991 by Parodi et al. using a
straight Dacron stent.1 With all new medical technol-
ogies there is an obligation to monitor patients
carefully, allowing early detection of device failure.
Many device-related complications associated with
endoluminal exclusion of abdominal aortic aneurysms
(AAA) have been reported, including loss of integrity
of the metallic endoskeleton. Review of the literature
revealed no reported incidences in the Zenith endo-
prosthesis. We report the first published cases with
Zenith graft strut failure, which occurred in three
patients at our institution.Materials and Methods
At our institution, endoluminal repair of AAA
commenced in 1996. Until now (2005), all patientsing author. Professor Tim Buckenham, MBChB, FRCR,
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Bloomington, IN, USA) stent-graft of second-
generation.
All repairs were entered onto a database that
facilitates recall for imaging surveillance, in addition
to clinical audit. From 1996 to 2005, 84 patients were
entered in the database, 66 of whom are currently
undergoing surveillance. Eighteen patients are not in
the programme as 12 patients are deceased, one is
terminally ill, two have withdrawn from surveillance
and three are awaiting their inaugural scan.
We routinely survey all our endoluminal aortic
stent-grafts with a combination of CT and/or colour
Doppler ultrasound (CDU) imaging according to a
rigid protocol. In addition, in 2003 plain anterior–
posterior (AP) and lateral abdominal radiographs
were introduced into this protocol, to be carried out
at the same time as other imaging. The abdominal
radiographs were introduced to allow detection of
strut failure and graft migration. Hence, from the
database we have identified a cohort of 70 patients
who have had plain radiograph imaging of their stent-
graft. These patients form the basis of this paper.
For monitoring of graft integrity we routinely
obtain AP and lateral plain abdominal radiographs,Eur J Vasc Endovasc Surg 32, 136–139 (2006)
doi:10.1016/j.ejvs.2006.01.018, available online at http://www.sciencedirect.com onved.
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views give reason for concern. In the beginning of the
surveillance program, plain radiographswere reviewed
by the general pool of abdominal radiologists; however,
one of the three strut failures in our series was missed
initially and was only noted on a second reading when
all studies were reviewed for this paper. This has led to
the entire CT, ultrasound and plain radiograph AAA
follow-ups now being reviewed by one specialist
Vascular Radiologist (Professor Tim Buckenham).Fig. 1. Lateral abdominal X-ray showing strut failure
(arrow).Results
The patient cohort comprised 65 men and five women,
aged 57–88 years (median 77 years), with pre-
implantation AAA diameters of 42–80 mm (median
58 mm) [maximum AP diameter in the transverse
plane from CDU] and a follow-up time of 0–90 months
(median 39 months). They have undergone a total of
1612 abdominal radiographs, range 1–7 per patient
(median 2). Three patients were found to have strut
failure, these cases are described below.Case 1
This 79-year-old man had an uncomplicated endo-
luminal repair of his 65 mm AAA in 1998. He was
commenced on the CT screening program after the
procedure and subsequent measurement of the
aneurysmal sac showed a maximal diameter of
70 mm in 2001. No significant abnormality was
detected until 2002 when CT scanning revealed a
type 2 endoleak via the inferior mesenteric artery
(IMA) with sac expansion. This was treated success-
fully via endoluminal coiling and occlusion of the IMA
origin. Further sac measurements have shown
ongoing shrinkage with maximal sac diameters of
64 mm in 2003 and 63 mm in both 2004 and 2005.
Plain radiographs of the endoluminal device in Jan
2003 revealed a strut failure in the distal body ring at
the site of the previously repaired endoleak (Fig. 1). No
association between the endoleak and strut failure was
thought to exist. Subsequent radiographs, with the
most recent in February 2005, have shown no new
strut failures and no change in the appearance of the
known strut failure.Case 2
This 72-year-old man had an endoluminal repair
performed in Feb 1998 for a 61 mmAAA.Theprocedure
was complicated by difficulty in passage of the shortlimb and an angioplasty was required. Due to insuffi-
cient overlap between the stent and short limb a 50 mm
extension piece was required. No evidence of endoleak
wasseenat theendof theprocedure.CTscanning in1999
showedno abnormality; sac size at this timewas 40 mm.
Plain abdominal radiographs in June 1999 showed no
strut failure. CT scanning June 2000 showed no
abnormality and a stable sac size. The patient re-
presented acutely in late 2000 with an acute retro-
peritoneal haemorrhage, which was attributed to a
contained AAA leak. The patient was treated conserva-
tively due to comorbidities precluding repair.
A CT in February 2001 revealed the aneurysmal sac
to be 40 mm in diameter and the presence of a small
endoleak of unknown type. Arteriography in August
2001 showed a left iliac limb endoleak at the junction
of the graft (type III). The patient had a left iliac limb
covered stent replacement with successful exclusion of
the endoleak. CTscanning in 2002 showed a sac size of
43 mm and no endoleak.
Plain radiographs of the graft in February 2004
revealed a strut failure in the inferior body ring of the
main aortic graft. This has remained unchanged and
was not associated with an endoleak. Ultrasonography
in 2005 showed no further endoleak and a sac size of
39 mm.Case 3
This patient underwent endoluminal repair of a
50 mm asymptomatic AAA in January 1999. AtEur J Vasc Endovasc Surg Vol 32, August 2006
A. Rumball-Smith et al.138insertion, note was made of some minor kinking at the
posterior aspect of the stent in the mid-aortic region.
There were otherwise no immediate complications
and subsequent CT scans were unremarkable. In 2001,
the aneurysm measured 32 mm, with no evidence of
an endoleak. Ultrasound of in 2003 showed a sac size
of 30 mm and the first plain radiograph of the stent at
this time showed a strut fracture in the inferior ring of
the main body of the stent. Further radiographs in
2004 showed no change in the strut appearances and
further shrinkage of the sac to 28 mm.Discussion
The Zenith endograft has evolved since its genesis in
1991. The first modular bifurcated graft was inserted
in July 1994 with over 10,000 Zenith AAA grafts
having subsequently been implanted. In December
1999, Zenith introduced their Tri-Fab system, which
was again a modular system, but this time based on
three individual components. The materials and
introducer were unchanged; however, the stent-graft
construction was altered with more flexibility in the
legs and alteration of the stent height in the mid
portion of the stent-graft. The current most popular
model is a modular bifurcated system with an
infrarenal body and suprarenal fixation via metallic
tines. The body is continuous with two limbs, one of
which is landed directly in the iliac of the accessed
side. The contralateral limb is docked into the
appropriate stump and landed in the contralateral
iliac. The graft itself comprises a stainless steel
endoskeleton with a Dacron outer sleeve. The sleeve
is attached to the endoskeleton with sutures.
All of the patients in our series received the second-
generation Zenith graft. UK experience of 269 patients
receiving this model suggests a success rate of
aneurysm exclusion of 94.1%, with 30 patients
(11.8%) developing type II endoleak.2 A large US
multi-center trial of the third-generation Zenith graft
showed 0% migration less than or equal to 10 mm,
98.7% rate of aneurysm size stabilizing or decreasing
and a 7.4% rate of all endoleaks.3 Despite the large
number of implants, no strut failures have been
reported, unlike other devices where this type of
complication has been well documented.4
The significance of the strut failures in our three
cases is uncertain. In our series, 28% of patients had an
endoleak and two out of the three strut failure patients
had an endoleak, but the strut failure was unlikely to
have an aetiological role. All strut failures were noted
in the distal ring of the body and there was no
associated fabric failure. All these strut failures wereEur J Vasc Endovasc Surg Vol 32, August 2006identified on AP and lateral plain radiographs, which
we performed as a routine follow-up in addition to CT
and ultrasound. The AP and lateral radiographs were
introduced to the follow-up in 2003, when reports of
strut failure were first published relating to other
endoluminal prostheses used for the exclusion of
abdominal aortic aneurysms. The three strut failures
have been reported to Medsafe and TGA, but we are
unable to find in the literature any other reports of
strut failure relating to the second-generation Zenith
graft.
Detection of the failures is not in itself a difficult
task, however, it is a finding that needs to be
specifically looked for. For this reason we believe
single reading by specialist vascular radiologists is
sufficient to monitor graft integrity. All of the strut
failures were evident on bi-planar imaging and this
appears to be adequate to monitor graft position and
assess strut integrity.
In the medical literature there is little published
research into the implications of strut failures in the
clinical setting. Although this is a recognised phenom-
enon there have been a small number of reported cases
with no clear adverse sequelae seen. From current
review of the literature there is no clear association of
generic strut failure with endoleak despite a number of
different models of AAA stents exhibiting strut
failures.4
As we believe this is the first reported case series of
strut failures in the Zenith graft it suggests there is a
paucity of published data showing any association
with strut failure in this graft type and significant
clinical consequences. Despite the occurrence of
endoleak at the site of our first patient’s strut failure
we appreciate that this may be a coincidental finding.
In each of our cases, further screening of the grafts has
shown neither further strut failures nor alteration in
graft morphology of position.
Correspondence with the manufacturers, Cook,
suggests that up to 2% of the first/second-generation
Zenith AAA grafts (those with 22 mm long stents)
have shown stent fractures (letter from Henrik Gyllun,
QC Manager, William Cook Europe ApS, March 6,
2003). The UK Medicines and Healthcare products
Regulatory Agency refer to this letter in their website
and also provide a summary of data on available
endoprostheses, including the Zenith, from the
Medical Devices Agency (see http://www.mhra.gov.
uk/home/idcplg?IdcServiceZSS_GET_PAGE&useSe-
condaryZtrue&ssDocNameZCON019583 and http://
www.mhra.gov.uk/home/groups/dts-bi/documents/
websiteresources/con019585.pdf). All of these fractures
were located in a similar position just above the
bifurcation and no adverse events or clinical sequelae
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This is somewhat reassuring and it will be interesting to
see if this known phenomenon of strut failure in the
main body is seen in the third-generation models.
Despite the apparent lack of clinical consequence
with strut failures in Zenith AAA grafts, it serves as a
good illustration of the principle that endovascularly
repaired AAA patients are indeed ‘patients for life’.
AAA repair via endovascular means is becoming the
norm rather than the exception in many institutions
and as in any new technology long term data for all
aspects of the procedure are still pending. As the
consequences of mechanical device failure, i.e. strut
failure, could be catastrophic it is seems prudent to
regard the patients as necessitating ongoing follow-up,
maybe even indefinitely. The nature of what is
‘appropriate’ follow-up is less clear. Due to the
inherent artefact produced by CT scanning of metallic
objects, as well as the spatial resolution obtained with
axial scanning it has taken the introduction of
abdominal X-ray screening in 2003 for the strut failures
in our case series to become apparent. We have taken
the conservative approach of yearly abdominal plain
radiographs corresponding with our ultrasound
screening as an initial policy. This may need adjustingas some of our cohort start to exceed a decade from
their initial procedure. However, until there is either
conclusive evidence that single strut failure is clini-
cally insignificant or newer generation models of graft
are shown to not exhibit the problem, it seems prudent
to continue with our current screening policy.References
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